Rationale and design of SAVI-AoS: A physiologic study of patients with symptomatic moderate aortic valve stenosis and preserved left ventricular ejection fraction.
Int J Cardiol Heart Vasc
; 41: 101063, 2022 Aug.
Article
en En
| MEDLINE
| ID: mdl-35663622
6MWT, 6-minute walking test; AOV max, Maximal aortic valve velocity; AS, Aortic stenosis; AVA, Aortic valve area; CCS, Canadian Cardiovascular Society; IQR, Interquartile range; KCCQ-OS, Kansas City Cardiomyopathy Questionnaire Overall Score; LV, Left ventricle/ventricular; LVEF, Left ventricular ejection fraction; LVOT, Left ventricular outflow tract; MAS:, Moderate aortic stenosis; MDCT, Multi-detector computed tomography; MG, Mean valve gradient; Moderate aortic stenosis; NT-proBNP, N-terminal pro-B-type natriuretic peptide; NYHA, New York Heart Association; SAVI; SAVI, Stress aortic valve index; SAVR, Surgical aortic valve replacement; TAVI, Transcatheter aortic valve implantation/replacement
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
/
Diagnostic_studies
/
Guideline
/
Prognostic_studies
/
Qualitative_research
Idioma:
En
Revista:
Int J Cardiol Heart Vasc
Año:
2022
Tipo del documento:
Article
País de afiliación:
Países Bajos